全文获取类型
收费全文 | 7615篇 |
免费 | 496篇 |
国内免费 | 162篇 |
专业分类
耳鼻咽喉 | 65篇 |
儿科学 | 175篇 |
妇产科学 | 350篇 |
基础医学 | 891篇 |
口腔科学 | 107篇 |
临床医学 | 905篇 |
内科学 | 1774篇 |
皮肤病学 | 77篇 |
神经病学 | 545篇 |
特种医学 | 421篇 |
外科学 | 981篇 |
综合类 | 146篇 |
一般理论 | 3篇 |
预防医学 | 373篇 |
眼科学 | 169篇 |
药学 | 621篇 |
中国医学 | 44篇 |
肿瘤学 | 626篇 |
出版年
2023年 | 46篇 |
2022年 | 83篇 |
2021年 | 197篇 |
2020年 | 97篇 |
2019年 | 163篇 |
2018年 | 211篇 |
2017年 | 152篇 |
2016年 | 126篇 |
2015年 | 231篇 |
2014年 | 296篇 |
2013年 | 392篇 |
2012年 | 575篇 |
2011年 | 522篇 |
2010年 | 310篇 |
2009年 | 333篇 |
2008年 | 460篇 |
2007年 | 444篇 |
2006年 | 385篇 |
2005年 | 410篇 |
2004年 | 357篇 |
2003年 | 288篇 |
2002年 | 239篇 |
2001年 | 222篇 |
2000年 | 185篇 |
1999年 | 191篇 |
1998年 | 79篇 |
1997年 | 53篇 |
1996年 | 57篇 |
1995年 | 56篇 |
1994年 | 44篇 |
1993年 | 29篇 |
1992年 | 113篇 |
1991年 | 83篇 |
1990年 | 86篇 |
1989年 | 65篇 |
1988年 | 76篇 |
1987年 | 71篇 |
1986年 | 63篇 |
1985年 | 66篇 |
1984年 | 68篇 |
1983年 | 32篇 |
1982年 | 23篇 |
1979年 | 37篇 |
1978年 | 27篇 |
1977年 | 23篇 |
1976年 | 18篇 |
1975年 | 33篇 |
1974年 | 23篇 |
1973年 | 19篇 |
1971年 | 17篇 |
排序方式: 共有8273条查询结果,搜索用时 15 毫秒
71.
Mei-Yu Yeh Su-Ching Sung Beatrice Crofts Yorker Chi-Chen Sun Ya-Lin Kuo 《Issues in mental health nursing》2013,34(7):701-717
This study explored the predictors of medication adherence among Taiwanese people with major depression and dysthymic disorder. Previous research indicates that depressed patients vary in compliance with their medication regimen. Poor compliance reduces the therapeutic effect of medication. Self-report questionnaires were used for this cross-sectional study conducted with 181 outpatients diagnosed with major depression or dysthymic disorder. About 50% of depressed patients reported good medication adherence. The predictors of adherence were patient income, treatment efficacy, and understanding the importance of continuing medication. Professionals should use collaborative communication and cultural values clarification with depressed patients and their families to improve the awareness of illness and to increase the likelihood of medication compliance. 相似文献
72.
73.
Rebecca Erwin Wells MD MPH Catherine E. Kerr PhD Jennifer Wolkin PhD Michelle Dossett MD PhD Roger B. Davis ScD Jacquelyn Walsh BS Robert B. Wall MDiv MSN Jian Kong MD MPH Ted Kaptchuk Daniel Press MD Russell S. Phillips MD Gloria Yeh MD MPH 《Journal of the American Geriatrics Society》2013,61(4):642-645
74.
75.
Serum osteocalcin and total body calcium in normal pre- and postmenopausal women and postmenopausal osteoporotic patients 总被引:1,自引:0,他引:1
S Yasumura J F Aloia C M Gundberg J Yeh A N Vaswani K Yuen A F Lo Monte K J Ellis S H Cohn 《The Journal of clinical endocrinology and metabolism》1987,64(4):681-685
Serum osteocalcin was measured in 51 normal pre- and 114 postmenopausal women and in 41 postmenopausal osteoporotic patients. Total body calcium (TBCa) was determined in the same individuals by neutron activation analysis. Many of the perimenopausal nonosteoporotic women had increased serum osteocalcin values, but 15 yr or more after the menopause most of the women had serum osteocalcin levels in the normal range. Comparing normal women before and after menopause, the mean serum osteocalcin levels [7.8 +/- 4.7 (+/- SE) and 10.1 +/- 9.4 ng/mL] were not significantly different; however, the TBCa values (898 +/- 99 and 806 +/- 111 g) were significantly different (P less than 0.001). When the normal postmenopausal women were regrouped according to high vs. low osteocalcin values, TBCa and phosphorus content as well as forearm linear bone density were significantly lower in the high osteocalcin group, even though most of the other variables, including urinary hydroxyproline excretion, serum alkaline phosphatase, age, height, and weight, were not different. Osteoporotic women had a mean serum osteocalcin concentration of 17.4 +/- 8.6 ng/ml and a TBCa of 657 +/- 83 g, both significantly different from the respective values in normal and pre- and postmenopausal women (P less than 0.001 for both variables in comparison to each group). These data suggest that high serum osteocalcin levels, at least on a group basis, are an index of low skeletal mass. 相似文献
76.
Hui-Fang Chang Yu-Ling Sun Fang-Yuan Yeh I-Hua Tseng Chia-Chu Chang Chih-Sheng Lin 《RSC advances》2018,8(51):29013
Gold nanoparticles (AuNPs) can be applied in biosensors using fluorescence resonance energy transfer (FRET) technique. Based on this technique, we have established a sensitive and efficient biosensing method by modifying a peptide-probe onto AuNPs to detect proteinase enzyme activity in this study. This biosensing method was designed for chymase activity detection and applied in kidney disease diagnosis. In this study, 16 nm-AuNPs were used to construct the AuNPs-based fluorescence peptide probe (named AuNPs-peptide probe) for chymase activity determination. The peptide sequence is FITC-Acp-DRVYIHPFHLDDDDDC, which comprises a fluorophore at the N-terminal end, an enzyme (chymase) substrate (DRVYIHPFHL), a spacer (DDDDD) and cysteine (C) to conjugate to AuNPs surface. When the enzyme catalyzes the substrate sequence, the fluorophore drifts away from AuNPs and the fluorescence emitting signal can be excited at 495 nm and detected at 515 nm. The results indicate that the time required for the AuNPs-peptide probe for activity detection of chymase was only 15 min, and a linear correlation from 10 to 100 ng mL−1 of chymase was acquired. The chymase reaction would be significantly inhibited by addition of specific chymase inhibitor chymostatin. The AuNPs-peptide probe was tested for the detection of high concentrations of trypsin and chymotrypsin, but only minor emitted fluorescence intensity was detected. According to these results, sensitivity and specificity of the AuNPs-peptide probe for chymase detection have been confirmed. AuNPs-peptide probe was successfully used for the detection of renal chymase activity; and the results indicate the pathogenically increased chymase activity in kidney tissue of nephropathic mice from aristolochic acid I treatment.The gold nanoparticles (AuNPs) peptide probe functionalized with specific peptide sequences was developed for the sensitive and efficient detection of chymase activity. 相似文献
77.
Yi-Wei Yeh Pei-Shen Ho Shin-Chang Kuo Chun-Yen Chen Chih-Sung Liang Che-Hung Yen Chang-Chih Huang Kuo-Hsing Ma Chyng-Yann Shiue Wen-Sheng Huang Jia-Fwu Shyu Fang-Jung Wan Ru-Band Lu San-Yuan Huang 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2015,18(7)
Background:
Many lines of evidence suggest the role of serotonin transporter (SERT)-mediated reuptake of serotonin in the pathophysiology and treatment of major depressive disorder (MDD). This study aimed to examine whether the pretreatment of SERT binding potential or SERT binding ratio between terminal projection regions relative to the midbrain raphe nuclei was associated with treatment outcomes to SERT-targeted antidepressants.Methods:
We recruited 39 antidepressant-naïve patients with MDD and 39 heathy controls. Positron emission tomography with N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine (4-[18F]-ADAM) was used to measure in vivo SERT availability prior to antidepressant treatment. The 21-item Hamilton Depression Rating Scale (HDRS) was use to assess the severity of depression from baseline to week 6. All the patients with MDD had HDRS scores of 18 or more.Results:
Pretreatment SERT binding in the thalamus and striatum positively correlated with an early reduction in HDRS scores at week 3. Nonresponders and dropout patients showed a proportionate reduction in SERT binding in the terminal projection regions and midbrain compared to healthy controls. In contrast, a disproportionate reduction in SERT binding in the terminal projection regions relative to midbrain was observed in responders.Conclusions:
The results of this study suggested that a disproportionate reduction in SERT binding between terminal projection regions and midbrain may predict better treatment outcomes in patients with MDD. 相似文献78.
Tzu-Wen Huang Jing-Yi Chen Yueh-Lin Wu Chih-Chin Kao Shu-Ching Yeh Yen-Chung Lin 《Medicine》2021,100(20)
Background:The aim of this study is to evaluate the alterations in bone mineral density and other surrogate markers for osteoporosis in obese patients with type 2 diabetes mellitus (T2DM) who received Roux-en-Y gastric bypass (RYGB) versus medical treatment as control.Methods:We searched 4 electronic databases and reference lists of relevant studies for eligible research published before December, 2019. After quality assessment, eligible studies were synthesized for relevant outcomes, including lumbar spine bone mineral density (L-spine BMD) change, total hip BMD change, osteocalcin level, C-terminal telopeptide level, and parathyroid hormone level.Results:Three randomized clinical trials and 2 observational studies concerning 307 total obese T2DM patients were included. Follow-up ranged from 12 to 60 months. Patients underwent RYGB surgery were associated with both higher L-spine BMD loss (mean difference: −2.90, 95% CI: −2.99∼−2.81, P < .00001) and total hip BMD loss (mean difference: −5.81, 95% CI: −9.22∼−2.40, P = .0008). As to biochemical markers of bone metabolism, we found significantly higher osteocalcin level in medical treatment (control) group compared with RYGB group (mean difference: 11.16, 95% CI: 8.57–13.75, P < .00001). However, higher C-terminal telopeptide level and parathyroid hormone level were noted in medical treatment group (control) compared with RYGB group (mean difference: 0.29, 95% CI: 0.11–0.48, P = .002; mean difference: 1.56, 95% CI: 0.84–2.27, P < .0001).Conclusions:RYGB surgery is associated with negative impact on bone metabolism and increase the risk of osteoporosis in obese patients with T2DM. We suggest that clinicians acknowledge the adverse effects of surgery and keep monitoring bone mineral components in post-RYGB populations. Further studies regarding the optimal amount of perioperative and postsurgical supplementation should be evaluated. 相似文献
79.
80.
P R Holt K Y Yeh D P Kotler 《Proceedings of the National Academy of Sciences of the United States of America》1988,85(8):2771-2775
The proximal small intestine responds to starvation by rapidly reducing crypt cell proliferation rate and villus cellularity and to resumption of food intake (refeeding) by abruptly increasing proliferation and the number of villus epithelial cells. We show that villus cellularity responds to starvation and refeeding similarly in young and aging animals. However, as compared to young animals, senescent rats showed increased basal DNA synthetic activity, starvation resulted in a smaller decrease in DNA labeling of crypt cells, and refeeding produced an abrupt broadening of the proliferative zone in older animals without concomitant increased numbers of villus cells. Such altered crypt proliferative responses resemble precancerous changes seen in the colon and the aberrant proliferation found in both small and large intestine after administration of the carcinogen dimethylhydrazine. 相似文献